🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Swiss Secondary Prevention and Rehabilitation Registry

Recruitingn/aAges any - anyAllUniversity Hospital, Basel, Switzerland
NCT05500859 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The SwissPR study is to continuously monitor patient characteristics and short- and long-term benchmark quality measures and outcomes of patients participating in a 12-week ambulatory CR program.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Participation in an ambulatory CR program (all age groups) * Written informed consent Exclusion Criteria: * Inability to follow an ambulatory CR program more than 3 weeks * Not willing to give informed consent * Inability to understand the informed consent due to language comprehension * Lack of discernment
💊

What it tests

  • Data collection at Baseline, 3 months after baseline (BL), 1-year follow-up, Telephone follow-up and questionnaire 3 years and 5 years after BL
📍

Where

1 site
University Hospital Basel, Division of Outpatient Cardiology
Basel, Switzerland
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy